Predicting Sleep, Smoking, and Lung Health Disparities in African American Adults
| Status: | Recruiting |
|---|---|
| Conditions: | Insomnia Sleep Studies, Smoking Cessation, Pulmonary |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 40 - 65 |
| Updated: | 7/12/2018 |
| Start Date: | June 1, 2018 |
| End Date: | March 31, 2023 |
| Contact: | Freda Patterson, PhD |
| Email: | fredap@udel.edu |
| Phone: | 302-831-6588 |
This 5-year prospective, observational study will: (1) determine the individual, social, and
environmental predictors of sleep duration, quality, latency, efficiency, timing and
regularity in African American smokers, (2) quantify the prospective relationship between
multiple metrics of sleep with tobacco use, such that a sleep phenotype of risk for smoking
is defined, and (3) examine the extent to which short sleep (<7 hrs) and other unhealthy
sleep metrics, predicts lung function through smoking behaviors and inflammation, in 480
African Americans at risk for advancing COPD (GOLD Stage 0-2 and current smoker). Study
subjects will be recruited via Temple Health System sites. Following eligibility screening,
initially eligible subjects will provide written study consent and complete an in-home sleep
assessment to rule out the exclusionary moderate-severe sleep apnea and other sleep
disorders. Consenting and eligible subjects will be entered into the study and across the
60-month data collection period, complete 8 assessments: 4 annual clinical based assessments,
interspersed by 4 mid-year, phone-based, self-report assessments.
environmental predictors of sleep duration, quality, latency, efficiency, timing and
regularity in African American smokers, (2) quantify the prospective relationship between
multiple metrics of sleep with tobacco use, such that a sleep phenotype of risk for smoking
is defined, and (3) examine the extent to which short sleep (<7 hrs) and other unhealthy
sleep metrics, predicts lung function through smoking behaviors and inflammation, in 480
African Americans at risk for advancing COPD (GOLD Stage 0-2 and current smoker). Study
subjects will be recruited via Temple Health System sites. Following eligibility screening,
initially eligible subjects will provide written study consent and complete an in-home sleep
assessment to rule out the exclusionary moderate-severe sleep apnea and other sleep
disorders. Consenting and eligible subjects will be entered into the study and across the
60-month data collection period, complete 8 assessments: 4 annual clinical based assessments,
interspersed by 4 mid-year, phone-based, self-report assessments.
Inclusion Criteria:
1. Self-reported African American ethnicity, or mixed ethnicity.
2. 40 - 65 years.
3. GOLD stage 0-2 as assessed by spirometry.
4. No moderate-severe sleep disorders or use of sleep medication.
5. Self-reported current cigarette smoker as defined by smoking one or more cigarettes in
the last month.
6. Able to communicate in English and provide written informed consent.
Exclusion Criteria:
1. Self-reported ethnicity (in full or part) other than Black/African American.
2. < 40 years of age.
3. Not a current cigarette smoker (< 1 cigarette in last month).
4. GOLD stage >2.
5. Presents with a diagnosed moderate-severe sleep disorder
6. Use of any sleep medication. -
We found this trial at
1
site
Click here to add this to my saved trials
